Literature DB >> 30310489

Statins: Practical Considerations - A Review.

Kazeen Abdullah1, Anand Rohatgi1.   

Abstract

Statins are currently the most efficacious and widely prescribed lipid-lowering medications. The 2013 ACC/AHA cholesterol guidelines provide a dramatic shift in treatment approach with a focus on fixed-dose statins matched to individual risk scores. Statin intolerance is not uncommon and can be challenging to diagnose and manage; however, several therapeutic strategies have been successful in achieving statin tolerance. Statin use is also associated with liver enzyme elevations and increased risk of incident diabetes, but studies show these individuals benefit from statins. Several guidelines exist and statin use is expected to increase with the new cholesterol guidelines bringing along new challenges for prescribers. This review article will provide practical considerations for statin use and management of statin intolerance.

Entities:  

Keywords:  ASCVD; CKD; Statin; cholesterol; considerations; diabetes; guidelines; intolerance; practical; review

Year:  2014        PMID: 30310489      PMCID: PMC6159457          DOI: 10.15420/ecr.2014.9.2.71

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  41 in total

1.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

2.  Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Authors:  Eric Bruckert; Gilles Hayem; Sylvie Dejager; Caroline Yau; Bernard Bégaud
Journal:  Cardiovasc Drugs Ther       Date:  2005-12       Impact factor: 3.727

3.  Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis.

Authors:  David Preiss; Sreenivasa Rao Kondapally Seshasai; Paul Welsh; Sabina A Murphy; Jennifer E Ho; David D Waters; David A DeMicco; Philip Barter; Christopher P Cannon; Marc S Sabatine; Eugene Braunwald; John J P Kastelein; James A de Lemos; Michael A Blazing; Terje R Pedersen; Matti J Tikkanen; Naveed Sattar; Kausik K Ray
Journal:  JAMA       Date:  2011-06-22       Impact factor: 56.272

Review 4.  Risks associated with statin therapy: a systematic overview of randomized clinical trials.

Authors:  Amir Kashani; Christopher O Phillips; JoAnne M Foody; Yongfei Wang; Sandeep Mangalmurti; Dennis T Ko; Harlan M Krumholz
Journal:  Circulation       Date:  2006-12-11       Impact factor: 29.690

5.  Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.

Authors:  Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew Levey; Paul de Jong; Ron T Gansevoort; Marije van der Velde; Kunihiro Matsushita; Josef Coresh; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Ron T Gansevoort; Andrew Levey; Meguid El-Nahas; Kai-Uwe Eckardt; Bertram L Kasiske; Toshiharu Ninomiya; John Chalmers; Stephen Macmahon; Marcello Tonelli; Brenda Hemmelgarn; Frank Sacks; Gary Curhan; Allan J Collins; Suying Li; Shu-Cheng Chen; K P Hawaii Cohort; Brian J Lee; Areef Ishani; James Neaton; Ken Svendsen; Johannes F E Mann; Salim Yusuf; Koon K Teo; Peggy Gao; Robert G Nelson; William C Knowler; Henk J Bilo; Hanneke Joosten; Nanno Kleefstra; K H Groenier; Priscilla Auguste; Kasper Veldhuis; Yaping Wang; Laura Camarata; Beverly Thomas; Tom Manley
Journal:  Kidney Int       Date:  2011-02-09       Impact factor: 10.612

6.  Diabetes and all-cause and coronary heart disease mortality among US male physicians.

Authors:  P A Lotufo; J M Gaziano; C U Chae; U A Ajani; G Moreno-John; J E Buring; J E Manson
Journal:  Arch Intern Med       Date:  2001-01-22

7.  Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.

Authors:  Charles J Glueck; Dawit Aregawi; Mahlia Agloria; Qasim Khalil; Magdalena Winiarska; Jitender Munjal; Srikanth Gogineni; Ping Wang
Journal:  Clin Ther       Date:  2006-06       Impact factor: 3.393

8.  Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population.

Authors:  D Noto; A B Cefalù; C M Barbagallo; M Sapienza; G Cavera; I Nardi; M Pagano; N Vivona; A Notarbartolo; M R Averna
Journal:  Nutr Metab Cardiovasc Dis       Date:  2008-06-20       Impact factor: 4.222

Review 9.  Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia.

Authors:  Terry A Jacobson
Journal:  Mayo Clin Proc       Date:  2008-06       Impact factor: 7.616

10.  Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors:  C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal:  Lancet       Date:  2010-11-08       Impact factor: 79.321

View more
  1 in total

1.  Statin therapy and risk of Alzheimer's and age-related neurodegenerative diseases.

Authors:  Georgina Torrandell-Haro; Gregory L Branigan; Francesca Vitali; Nophar Geifman; Julie M Zissimopoulos; Roberta Diaz Brinton
Journal:  Alzheimers Dement (N Y)       Date:  2020-11-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.